Consultorio Medico

Mexico City

0 studies enrolling now · 2 studies all time

What they study most

Fatty Liver, Liver Diseases, Liver Fibroses, Non-Alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH — Completed